David H. Bollinger

Array ( [id] => 6544916 [patent_doc_number] => 20020137698 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2002-09-26 [patent_title] => 'ANTISENSE INHIBITION OF RAD51' [patent_app_type] => new [patent_app_number] => 09/260624 [patent_app_country] => US [patent_app_date] => 1999-03-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 5696 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0137/20020137698.pdf [firstpage_image] =>[orig_patent_app_number] => 09260624 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4136341 [patent_doc_number] => 06121434 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2000-09-19 [patent_title] => 'G cap-stabilized oligonucleotides' [patent_app_type] => 1 [patent_app_number] => 9/258408 [patent_app_country] => US [patent_app_date] => 1999-02-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10482 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 8 [patent_words_short_claim] => 122 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/121/06121434.pdf [firstpage_image] =>[orig_patent_app_number] => 258408 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6876664 [patent_doc_number] => 20010006817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-07-05 [patent_title] => 'CELL DELIVERY COMPOSITIONS' [patent_app_type] => new-utility [patent_app_number] => 09/251783 [patent_app_country] => US [patent_app_date] => 1999-02-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 15 [patent_no_of_words] => 6606 [patent_no_of_claims] => 92 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0006/20010006817.pdf [firstpage_image] =>[orig_patent_app_number] => 09251783 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4245243 [patent_doc_number] => 06221615 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-04-24 [patent_title] => 'Peptides and compositions which modulate apoptosis' [patent_app_type] => 1 [patent_app_number] => 9/236385 [patent_app_country] => US [patent_app_date] => 1999-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 18 [patent_no_of_words] => 13626 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 98 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/221/06221615.pdf [firstpage_image] =>[orig_patent_app_number] => 236385 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4407939 [patent_doc_number] => 06228649 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-05-08 [patent_title] => 'Double targeted gene replacement in unicellular diploid organisms' [patent_app_type] => 1 [patent_app_number] => 9/236149 [patent_app_country] => US [patent_app_date] => 1999-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5355 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 59 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/228/06228649.pdf [firstpage_image] =>[orig_patent_app_number] => 236149 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1417921 [patent_doc_number] => 06506559 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-01-14 [patent_title] => 'Genetic inhibition by double-stranded RNA' [patent_app_type] => B1 [patent_app_number] => 09/215257 [patent_app_country] => US [patent_app_date] => 1998-12-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 19 [patent_no_of_words] => 14022 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 120 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/506/06506559.pdf [firstpage_image] =>[orig_patent_app_number] => 09215257 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6839177 [patent_doc_number] => 20030036517 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'NUCLEIC ACID MEDIATED RNA TAGGING AND RNA REVISION' [patent_app_type] => new [patent_app_number] => 09/205520 [patent_app_country] => US [patent_app_date] => 1998-12-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 12988 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0036/20030036517.pdf [firstpage_image] =>[orig_patent_app_number] => 09205520 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1446332 [patent_doc_number] => 06368793 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-09 [patent_title] => 'Metabolic selection methods' [patent_app_type] => B1 [patent_app_number] => 09/172952 [patent_app_country] => US [patent_app_date] => 1998-10-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 13 [patent_no_of_words] => 30984 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 150 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/368/06368793.pdf [firstpage_image] =>[orig_patent_app_number] => 09172952 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1531076 [patent_doc_number] => 06410007 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-06-25 [patent_title] => 'Antagonism of endothelin actions' [patent_app_type] => B1 [patent_app_number] => 09/152874 [patent_app_country] => US [patent_app_date] => 1998-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 5 [patent_no_of_words] => 7347 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 51 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/410/06410007.pdf [firstpage_image] =>[orig_patent_app_number] => 09152874 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 4314184 [patent_doc_number] => 06242427 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-05 [patent_title] => 'Methods of inhibiting phagocytosis' [patent_app_type] => 1 [patent_app_number] => 9/158980 [patent_app_country] => US [patent_app_date] => 1998-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 15 [patent_figures_cnt] => 21 [patent_no_of_words] => 13415 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 29 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/242/06242427.pdf [firstpage_image] =>[orig_patent_app_number] => 158980 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6908309 [patent_doc_number] => 20010011076 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2001-08-02 [patent_title] => 'COMBINATIONS OF PKC INHIBITORS AND THERAPEUTIC AGENTS FOR TREATING CANCERS' [patent_app_type] => new [patent_app_number] => 09/137442 [patent_app_country] => US [patent_app_date] => 1998-08-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 12 [patent_no_of_words] => 47516 [patent_no_of_claims] => 35 [patent_no_of_ind_claims] => 9 [patent_words_short_claim] => 26 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0011/20010011076.pdf [firstpage_image] =>[orig_patent_app_number] => 09137442 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1127365 [patent_doc_number] => 06790944 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-09-14 [patent_title] => 'DNA encoding IGA nephropathy indicating protein' [patent_app_type] => B1 [patent_app_number] => 09/129603 [patent_app_country] => US [patent_app_date] => 1998-08-05 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 2 [patent_no_of_words] => 12354 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/790/06790944.pdf [firstpage_image] =>[orig_patent_app_number] => 09129603 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1274466 [patent_doc_number] => 06649596 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-11-18 [patent_title] => 'Modified VEGF Oligonucleotides for Inhibition of tumor growth' [patent_app_type] => B1 [patent_app_number] => 09/124304 [patent_app_country] => US [patent_app_date] => 1998-07-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 9 [patent_no_of_words] => 12027 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 129 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/649/06649596.pdf [firstpage_image] =>[orig_patent_app_number] => 09124304 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6838489 [patent_doc_number] => 20030035829 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-02-20 [patent_title] => 'LIPOSOMAL COMPOSITIONS FOR THE DELIVERY OF NUCLEIC ACID CATALYSTS' [patent_app_type] => new [patent_app_number] => 09/122588 [patent_app_country] => US [patent_app_date] => 1998-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 15134 [patent_no_of_claims] => 61 [patent_no_of_ind_claims] => 23 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0035/20030035829.pdf [firstpage_image] =>[orig_patent_app_number] => 09122588 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1400677 [patent_doc_number] => 06537972 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2003-03-25 [patent_title] => 'Compositions and methods for inhibiting human immunodeficiency virus infection by down-regulating human cellular genes' [patent_app_type] => B1 [patent_app_number] => 09/087609 [patent_app_country] => US [patent_app_date] => 1998-05-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 26 [patent_no_of_words] => 17720 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/537/06537972.pdf [firstpage_image] =>[orig_patent_app_number] => 09087609 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 1192807 [patent_doc_number] => 06730498 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2004-05-04 [patent_title] => 'Production of functional proteins: balance of shear stress and gravity' [patent_app_type] => B1 [patent_app_number] => 09/056363 [patent_app_country] => US [patent_app_date] => 1998-04-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 14 [patent_no_of_words] => 11171 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 104 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/730/06730498.pdf [firstpage_image] =>[orig_patent_app_number] => 09056363 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 6674829 [patent_doc_number] => 20030060432 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2003-03-27 [patent_title] => 'ANTAGONISTS OF THE ONCOGENIC ACTIVITY OF THE PROTEIN MDM2, AND USE THEREOF IN THE TREATMENT OF CANCERS' [patent_app_type] => new [patent_app_number] => 09/029327 [patent_app_country] => US [patent_app_date] => 1998-03-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7378 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 19 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0060/20030060432.pdf [firstpage_image] =>[orig_patent_app_number] => 09029327 [rel_patent_id] =>[rel_patent_doc_number] =>)